(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Life Science Industry Banner - Advancing Healthcare Solutions
Mouse Scroll Icon
February 2021

Tom Polen to be Chairman of BD’s Board of Directors

BD (Becton, Dickinson and Company) will expand Tom Polen’s role to include Chairman of the Board of Directors beginning April 28, 2021. Tom is currently BD’s Chief Executive Officer and President. Tom has served in several leadership roles over the past 13 years, including Chief Operating Officer and Segment President of BD Medical. He succeeds Vincent A. Forlenza as Chairman, who announced he will retire from the company on the same date.

Becton, Dickinson and Company (BD) is a global medical technology company engaged principally in the development, manufacture, and sale of medical devices, instrument systems, and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Headquartered in Franklin Lakes, NJ, BD currently employs nearly 50,000 associates across 50 countries. BD reported revenues of $17.29 billion for fiscal year 2019.